Low-dose blood thinners for people on ECMO
Part of Heart & circulation, Infections, Lungs & breathing clinical trials.
This study tests whether using lower doses of two blood thinners, argatroban and enoxaparin, is safe and works well for people on ECMO. ECMO is a machine that helps your heart and lungs work when they are very sick, and this trial aims to reduce bleeding risks while keeping blood from clotting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult, age 18 or older.
- You must currently be on ECMO (a machine that supports your heart and lungs).
- You must be receiving blood thinners called argatroban or enoxaparin.
- You must not be pregnant or breastfeeding.
- You must not have known allergies to these blood thinners or their ingredients.
- You cannot be enrolled in the lung transplant program at Motol University Hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares three different blood thinners (heparin, argatroban, and enoxaparin) used during ECMO support. It aims to find the safest and most effective way to prevent blood clots while on ECMO.
This trial studies whether people on a breathing machine called VV-ECMO can be managed without routine blood thinners, to reduce bleeding risk. It is meant for adults with severe lung failure (ARDS) and checks that it is safe for you to avoid anticoagulation.
This Phase 2 trial compares two blood-thinning medicines—bivalirudin and heparin—in people on ECMO (a machine that supports breathing and/or circulation). It aims to see which medicine works better and is safer while you are connected to the ECMO circuit.
This trial tests a way to manage blood clotting in patients on ECMO (a machine that helps breathe for very sick patients). It uses a drug called Nafamostat with a lower dose of standard blood thinners, which may reduce bleeding risks.
This trial tests if bivalirudin is a safe and effective blood thinner for people on ECMO, a machine that helps your heart and lungs. You may be eligible if you need this therapy and have no past reactions to similar medicines.
This study tests whether adding a medicine called prostacyclin (which helps keep blood from clotting) to the standard blood thinner can help children on ECMO—a machine that takes over heart and lung function—have fewer clotting problems and bleeding issues.
Hear when a new Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.